Professor Peter Johnson, NHS National Clinical Director for Cancer, said: “This cutting-edge therapy has shown real promise in trials and could give patients with this aggressive form of leukaemia a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback